Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mipomersen in Homozygous Familial Hypercholesterolemia
NCT00607373Phase 3Completed
- Sponsor
- Kastle Therapeutics LLC
- Start
- Jul 2007
- Primary completion
- Mar 2009
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 7
01
Overview
A Phase 3 trial of mipomersen in homozygous familial hypercholesterolemia (HoFH), sponsored by Kastle Therapeutics LLC. Started Jul 2007; status: completed.
02
Drugs
mipomersen
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT00607373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607373.